NCT07282691 Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders
| NCT ID | NCT07282691 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Salus University |
| Condition | MTBI - Mild Traumatic Brain Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2028-09-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2025-04-01 with a primary completion date of 2028-09-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of mTBI within previous 1 to 6 months * Distance visual acuity better than or equal to 20/25 in each eye * Score \>21 on Convergence Insufficiency Symptom Survey Exclusion Criteria: * Diagnosis of moderate or severe TBI; \> 30-min loss of consciousness * Not wearing required refractive error) * Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination) * Cognitive delays that may impact testing
Contact & Investigator
Mitchell Scheiman
STUDY CHAIR
Pennsylvania College of Optometry at Drexel University
Frequently Asked Questions
Who can join the NCT07282691 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying MTBI - Mild Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07282691 currently recruiting?
Yes, NCT07282691 is actively recruiting participants. Contact the research team at kh3482@drexel.edu for enrollment information.
Where is the NCT07282691 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT07282691 clinical trial?
NCT07282691 is sponsored by Salus University. The principal investigator is Mitchell Scheiman at Pennsylvania College of Optometry at Drexel University. The trial plans to enroll 150 participants.